
{"id":13633,"date":"2025-02-17T17:04:28","date_gmt":"2025-02-17T17:04:28","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/"},"modified":"2026-02-11T09:43:48","modified_gmt":"2026-02-11T09:43:48","slug":"sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president","status":"publish","type":"post","link":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/","title":{"rendered":"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d&rsquo;un nouveau vice-pr\u00e9sident."},"content":{"rendered":"<p><span style=\"font-size: 18pt;\"><strong>Sygnature Discovery est ravie d&rsquo;annoncer la nomination de Fraser McIntosh au poste de vice-pr\u00e9sident, Pharmacologie <em>in vivo<\/em> . Fort de 30 ans d&rsquo;exp\u00e9rience et d&rsquo;un parcours jalonn\u00e9 de succ\u00e8s, Fraser dirigera les activit\u00e9s de d\u00e9couverte de m\u00e9dicaments in vivo de l&rsquo;entreprise \u00e0 l&rsquo;\u00e9chelle mondiale. <\/strong><\/span><\/p>\n<p><span style=\"font-size: 14pt;\">La vaste exp\u00e9rience de Fraser en tant que cadre sup\u00e9rieur dans la d\u00e9couverte de m\u00e9dicaments couvre les secteurs pharmaceutique, biotechnologique et des organismes de recherche sous contrat. Il a pilot\u00e9 de nombreux programmes jusqu&rsquo;au d\u00e9veloppement clinique et favoris\u00e9 la collaboration interfonctionnelle dans divers domaines th\u00e9rapeutiques et modalit\u00e9s d&rsquo;administration de m\u00e9dicaments. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Chez Sygnature, Fraser pilotera les activit\u00e9s de pharmacologie in vivo, d\u00e9finissant l&rsquo;orientation strat\u00e9gique et assurant l&rsquo;excellence scientifique et op\u00e9rationnelle sur les sites de l&rsquo;entreprise au Royaume-Uni et au Canada. Il identifiera de nouvelles opportunit\u00e9s commerciales, int\u00e9grera des m\u00e9thodologies de pointe et veillera au respect des normes \u00e9thiques et r\u00e9glementaires les plus strictes pour tous les projets in vivo. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Commentant son nouveau r\u00f4le, Fraser a d\u00e9clar\u00e9&nbsp;: \u00ab&nbsp;Je suis ravi de rejoindre Sygnature Discovery \u00e0 un moment aussi crucial de la croissance de l\u2019entreprise et de contribuer \u00e0 cette nouvelle phase de d\u00e9veloppement. Les \u00e9quipes scientifiques talentueuses de Sygnature jouissent d\u2019une excellente r\u00e9putation pour la mise au point de candidats m\u00e9dicaments dans de nombreux domaines th\u00e9rapeutiques. Je suis impatient de mettre \u00e0 profit mon exp\u00e9rience en mati\u00e8re de d\u00e9couverte de m\u00e9dicaments pour b\u00e2tir un d\u00e9partement de pharmacologie in vivo mondial et int\u00e9gr\u00e9, qui soutienne la vision de Sygnature&nbsp;: devenir le leader mondial des CRO en d\u00e9couverte de m\u00e9dicaments.&nbsp;\u00bb  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Le Dr Simon Hirst, PDG de Sygnature Discovery, a ajout\u00e9&nbsp;: \u00ab&nbsp;L\u2019expertise de Fraser en mati\u00e8re de direction d\u2019op\u00e9rations de pharmacologie in vivo \u00e0 l\u2019\u00e9chelle mondiale est un atout consid\u00e9rable pour le d\u00e9veloppement de notre offre \u00e0 la client\u00e8le. Sa vision de la croissance commerciale et de l\u2019excellence scientifique s\u2019inscrit parfaitement dans la culture d\u2019innovation et de collaboration de Sygnature.&nbsp;\u00bb<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-size: 18pt;\"><strong>\u00c0 propos de Sygnature Discovery<\/strong><\/span><\/p>\n<p><span style=\"font-size: 18pt;\"><strong>Sygnature Discovery est une organisation de recherche contractuelle int\u00e9gr\u00e9e <em>de premier plan dans<\/em> le domaine de la d\u00e9couverte de m\u00e9dicaments, bas\u00e9e au Royaume-Uni et au Canada, avec son si\u00e8ge social \u00e0 Nottingham (Royaume-Uni). D&rsquo;autres sites sont situ\u00e9s \u00e0 Alderley Park, Macclesfield et Glasgow (Royaume-Uni), ainsi qu&rsquo;\u00e0 Montr\u00e9al et Qu\u00e9bec (Canada). Son \u00e9quipe de plus de 1 000 employ\u00e9s, dont 900 scientifiques, collabore avec des organisations mondiales de biotechnologie, pharmaceutiques et \u00e0 but non lucratif. Depuis 2011, Sygnature Discovery a mis au point 50 nouveaux compos\u00e9s pr\u00e9cliniques et 30 compos\u00e9s cliniques, et ses scientifiques sont cit\u00e9s dans plus de 170 brevets. Ses domaines d&rsquo;expertise th\u00e9rapeutique comprennent l&rsquo;oncologie, l&rsquo;inflammation et l&rsquo;immunologie, les neurosciences, les maladies m\u00e9taboliques, les maladies infectieuses, les maladies fibrotiques, et bien plus encore.<\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":13635,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"category":[816],"tags":[],"class_list":["post-13633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmacologie-in-vivo"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d&#039;un nouveau vice-pr\u00e9sident. - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d&#039;un nouveau vice-pr\u00e9sident. - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-17T17:04:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-11T09:43:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Fraser-Mcintosh-1024x571.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"571\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"pnpd-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"pnpd-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/\"},\"author\":{\"name\":\"pnpd-admin\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\"},\"headline\":\"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d&rsquo;un nouveau vice-pr\u00e9sident.\",\"datePublished\":\"2025-02-17T17:04:28+00:00\",\"dateModified\":\"2026-02-11T09:43:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/\"},\"wordCount\":528,\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Fraser-Mcintosh.png\",\"articleSection\":[\"pharmacologie in vivo\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/\",\"name\":\"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d'un nouveau vice-pr\u00e9sident. - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Fraser-Mcintosh.png\",\"datePublished\":\"2025-02-17T17:04:28+00:00\",\"dateModified\":\"2026-02-11T09:43:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Fraser-Mcintosh.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Fraser-Mcintosh.png\",\"width\":8136,\"height\":4537},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d&#8217;un nouveau vice-pr\u00e9sident.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\",\"name\":\"pnpd-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"caption\":\"pnpd-admin\"},\"sameAs\":[\"http:\\\/\\\/www.sygnaturediscovery.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d'un nouveau vice-pr\u00e9sident. - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/","og_locale":"fr_CA","og_type":"article","og_title":"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d'un nouveau vice-pr\u00e9sident. - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/","og_site_name":"Sygnature","article_published_time":"2025-02-17T17:04:28+00:00","article_modified_time":"2026-02-11T09:43:48+00:00","og_image":[{"width":1024,"height":571,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Fraser-Mcintosh-1024x571.png","type":"image\/png"}],"author":"pnpd-admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"pnpd-admin","Estimation du temps de lecture":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/#article","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/"},"author":{"name":"pnpd-admin","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448"},"headline":"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d&rsquo;un nouveau vice-pr\u00e9sident.","datePublished":"2025-02-17T17:04:28+00:00","dateModified":"2026-02-11T09:43:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/"},"wordCount":528,"publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Fraser-Mcintosh.png","articleSection":["pharmacologie in vivo"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/","name":"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d'un nouveau vice-pr\u00e9sident. - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Fraser-Mcintosh.png","datePublished":"2025-02-17T17:04:28+00:00","dateModified":"2026-02-11T09:43:48+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Fraser-Mcintosh.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Fraser-Mcintosh.png","width":8136,"height":4537},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-dynamise-la-croissance-de-son-activite-de-pharmacologie-in-vivo-avec-la-nomination-dun-nouveau-vice-president\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Sygnature Discovery dynamise la croissance de son activit\u00e9 de pharmacologie in vivo avec la nomination d&#8217;un nouveau vice-pr\u00e9sident."}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448","name":"pnpd-admin","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","caption":"pnpd-admin"},"sameAs":["http:\/\/www.sygnaturediscovery.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/comments?post=13633"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13633\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13635"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/tags?post=13633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}